X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (206) 206
male (157) 157
female (146) 146
middle aged (127) 127
index medicus (121) 121
aged (112) 112
adult (109) 109
oncology (79) 79
surgery (69) 69
aged, 80 and over (65) 65
cancer (60) 60
lung neoplasms - pathology (55) 55
prognosis (55) 55
respiratory system (50) 50
lung neoplasms - genetics (48) 48
metastasis (42) 42
medical colleges (37) 37
retrospective studies (37) 37
immunohistochemistry (36) 36
tumors (34) 34
neoplasm staging (32) 32
mutation (31) 31
adenocarcinoma - genetics (29) 29
lung cancer (29) 29
cardiac & cardiovascular systems (27) 27
treatment outcome (27) 27
survival (26) 26
adenocarcinoma (25) 25
lung neoplasms - metabolism (25) 25
medicine, general & internal (25) 25
receptor, epidermal growth factor - genetics (25) 25
animals (24) 24
carcinoma (24) 24
adolescent (23) 23
analysis (23) 23
lung neoplasms - mortality (23) 23
squamous cell carcinoma (23) 23
medicine (22) 22
carcinoma, non-small-cell lung - genetics (21) 21
cell line, tumor (21) 21
chemotherapy (20) 20
head (20) 20
hematology, oncology and palliative medicine (20) 20
neoplasm invasiveness (20) 20
pathology (20) 20
tomography, x-ray computed (20) 20
lung neoplasms - surgery (19) 19
survival analysis (19) 19
care and treatment (18) 18
diagnosis (18) 18
lung neoplasms - drug therapy (18) 18
lymphatic metastasis (18) 18
adenocarcinoma - pathology (17) 17
carcinoma, non-small-cell lung - pathology (17) 17
child (17) 17
expression (17) 17
follow-up studies (17) 17
lung cancer, non-small cell (17) 17
multivariate analysis (16) 16
survival rate (16) 16
taiwan (16) 16
diagnosis, differential (15) 15
genetic aspects (15) 15
neck (15) 15
research (15) 15
young adult (15) 15
abridged index medicus (14) 14
biopsy (14) 14
carcinoma, squamous cell - pathology (14) 14
gefitinib (14) 14
kaplan-meier estimate (14) 14
medicine & public health (14) 14
mice (14) 14
multidisciplinary sciences (14) 14
adenocarcinoma - metabolism (13) 13
carcinoma, non-small-cell lung - metabolism (13) 13
cardiology and cardiovascular medicine (13) 13
disease-free survival (13) 13
neoplasm metastasis (13) 13
otorhinolaryngology (13) 13
polymerase chain reaction (13) 13
pulmonary and respiratory medicine (13) 13
adenocarcinoma - drug therapy (12) 12
carcinoma, non-small-cell lung - secondary (12) 12
cardiothoracic surgery (12) 12
gene expression regulation, neoplastic (12) 12
internal medicine (12) 12
proto-oncogene proteins - genetics (12) 12
adenocarcinoma - mortality (11) 11
child, preschool (11) 11
combined modality therapy (11) 11
egfr (11) 11
mutation - genetics (11) 11
neoplasm recurrence, local - pathology (11) 11
therapy (11) 11
carcinoma, non-small-cell lung - mortality (10) 10
development and progression (10) 10
immunotherapy (10) 10
lung (10) 10
metastases (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 57, pp. 91 - 103
Abstract Background Programmed cell death-ligand 1 (PD-L1) is expressed in a subgroup of lung cancer that may benefit from immunotherapy. The interaction... 
Hematology, Oncology and Palliative Medicine | Immune microenvironment | Programmed cell-death ligand 1 | Squamous cell carcinoma | Immunotherapy | LUNG | SAFETY | PD-L1 EXPRESSION | B7-H1 EXPRESSION | TUMOR-INFILTRATING LYMPHOCYTES | TYROSINE KINASE INHIBITORS | GROWTH-FACTOR RECEPTOR | ANTI-PD-L1 ANTIBODY | ONCOLOGY | T-CELLS | Receptor, Epidermal Growth Factor - genetics | Prognosis | Lung Neoplasms - mortality | Proto-Oncogene Proteins p21(ras) - genetics | Carcinoma, Squamous Cell - genetics | Humans | Middle Aged | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Male | Phosphatidylinositol 3-Kinases - metabolism | CD4-Positive T-Lymphocytes - immunology | Receptor, Epidermal Growth Factor - metabolism | Carcinoma, Squamous Cell - mortality | Forkhead Transcription Factors - metabolism | Aged, 80 and over | Adult | Female | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins p21(ras) - metabolism | Lung Neoplasms - genetics | Kaplan-Meier Estimate | Mutation - genetics | Receptor Protein-Tyrosine Kinases - metabolism | Carcinoma, Squamous Cell - immunology | Tumor Microenvironment - immunology | B7-H1 Antigen - metabolism | Lung Neoplasms - immunology | Class I Phosphatidylinositol 3-Kinases | Proto-Oncogene Proteins B-raf - genetics | Aged | CD8-Positive T-Lymphocytes - immunology | Medical colleges | Lung cancer | Patient outcomes | Biochemistry | Apoptosis
Journal Article
European Journal of Cancer, ISSN 0959-8049, 06/2016, Volume 60, p. 125
Pulmonary pleomorphic carcinomas (PPCs) are uncommon malignant tumours characterised by an aggressive clinical course and poor survival. These neoplasms... 
Medical colleges | Chemotherapy | Cancer | Necrosis | Carcinoma | Sarcoma | Immunotherapy | Lymphomas
Journal Article
Nature Communications, ISSN 2041-1723, 2013, Volume 4, Issue 1, p. 1877
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e20572 - e20572
Journal Article
Nature Cell Biology, ISSN 1465-7392, 2009, Volume 11, Issue 6, pp. 694 - 704
Journal Article
Nature Communications, ISSN 2041-1723, 03/2014, Volume 5, Issue 1, p. 3472
Journal Article
Lung Cancer, ISSN 0169-5002, 2015, Volume 88, Issue 3, pp. 254 - 259
Highlights • PD-L1 refers to a target for immunotherapy of NSCLC, but its role in LELC is unclear. • LELC is highly associated with EBV infection. • Driver... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | Driver mutation | Immunotherapy | Lung cancer | PD-L1 | Pulmonary lymphoepithelioma-like carcinoma | KRAS | EGFR | TUMOR B7-H1 | SAFETY | ANTIBODY | GENE MUTATION | CANCER | CELL CARCINOMA | LYMPHOMAS | GROWTH-FACTOR RECEPTOR | ONCOLOGY | RESPIRATORY SYSTEM | DRIVER MUTATIONS | Immunohistochemistry | Receptor, Epidermal Growth Factor - genetics | ras Proteins - genetics | Prognosis | Lung Neoplasms - mortality | Protein-Tyrosine Kinases - metabolism | Humans | Middle Aged | Carcinoma - mortality | ras Proteins - metabolism | Lung Neoplasms - pathology | Male | Neoplasm Metastasis | Protein-Tyrosine Kinases - genetics | Receptor, Epidermal Growth Factor - metabolism | Aged, 80 and over | Adult | Female | Carcinoma - pathology | Proto-Oncogene Proteins B-raf - metabolism | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Gene Expression | Proto-Oncogene Proteins - genetics | Lung Neoplasms - therapy | Receptor Protein-Tyrosine Kinases - metabolism | B7-H1 Antigen - genetics | B7-H1 Antigen - metabolism | Receptor Protein-Tyrosine Kinases - genetics | Proto-Oncogene Proteins B-raf - genetics | Carcinoma - genetics | Carcinoma - therapy | Aged | Neoplasm Staging | Cohort Studies | Medical colleges | Lung cancer, Non-small cell | Drug therapy | Health aspects | Medical research | Epidermal growth factor | Carcinoma | Cell death | Analysis | Medicine, Experimental | Lymphomas | Cancer
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2008, Volume 14, Issue 15, pp. 4877 - 4882
Journal Article
Human Pathology, ISSN 0046-8177, 2016, Volume 56, pp. 134 - 142
Journal Article
Lung Cancer, ISSN 0169-5002, 2011, Volume 74, Issue 1, pp. 132 - 138
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 06/2017, Volume 12, Issue 6, pp. e75 - e76
Journal Article
Journal Article